Next, RNA-Seq was conducted to explore the downstream gene of lnc-ZEB2-19, and RSPH14, a gene recognized as a prognostic marker in HCC20 and NSCLC34 for the promotion of cancer progression, was selected and demonstrated to be a common target of lnc-ZEB2-19 and TRA2A. The gene discussed is TRA2A; the disease is cancer.